bs-43195P-Biotin [Conjugated Protein]
Recombinant SARS-Cov-2 Spike protein RBD (BA.2.86), (HEK293), Biotin Conjugated
www.biossusa.com
support@biossusa.com
800.501.7654 [DOMESTIC]
+1.781.569.5821 [INTERNATIONAL]
DATASHEET

Entrez Gene: 43740568

Swiss Prot: P0DTC2

Source: Recombinant SARS-Cov-2 Spike protein RBD (BA.2.86) is expressed in HEK293 cell with C-His. It contains the amino acid sequence of 319-537/1273

Storage Buffer: Lyophilized from 0.22um filtered solution in 20mM PB (pH 7.4). 5% trehalose is added as a protectant before lyophilization.

Storage: The product should be stored at -70°C or -20°C.

Background:

The SARS-CoV-2 spike (S) protein is the target of vaccine design efforts to end the COVID-19 pandemic. Despite a low mutation rate, isolates with the D614G substitution in the S protein appeared early during the pandemic, and are now the dominant form worldwide. Here, we analyze the D614G mutation in the context of a soluble S ectodomain construct.

Sequence: 319-537/1273

Conjugation: Biotin

Excitation/ Emission: N/A

Size: 100µg, 500µg, 20µg

Applications: Others

Predicted Molecular Weight: 26.7


Cross Reactive Species: Others

For research use only. Not intended for diagnostic or therapeutic use.